SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(O'Sullivan John) "

Search: WFRF:(O'Sullivan John)

  • Result 1-10 of 29
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Falster, Daniel, et al. (author)
  • AusTraits, a curated plant trait database for the Australian flora
  • 2021
  • In: Scientific Data. - : Nature Portfolio. - 2052-4463. ; 8:1
  • Journal article (peer-reviewed)abstract
    • We introduce the AusTraits database - a compilation of values of plant traits for taxa in the Australian flora (hereafter AusTraits). AusTraits synthesises data on 448 traits across 28,640 taxa from field campaigns, published literature, taxonomic monographs, and individual taxon descriptions. Traits vary in scope from physiological measures of performance (e.g. photosynthetic gas exchange, water-use efficiency) to morphological attributes (e.g. leaf area, seed mass, plant height) which link to aspects of ecological variation. AusTraits contains curated and harmonised individual- and species-level measurements coupled to, where available, contextual information on site properties and experimental conditions. This article provides information on version 3.0.2 of AusTraits which contains data for 997,808 trait-by-taxon combinations. We envision AusTraits as an ongoing collaborative initiative for easily archiving and sharing trait data, which also provides a template for other national or regional initiatives globally to fill persistent gaps in trait knowledge.
  •  
2.
  • Anderson, Beverley H., et al. (author)
  • Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus
  • 2012
  • In: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 44:3, s. 338-342
  • Journal article (peer-reviewed)abstract
    • Coats plus is a highly pleiotropic disorder particularly affecting the eye, brain, bone and gastrointestinal tract. Here, we show that Coats plus results from mutations in CTC1, encoding conserved telomere maintenance component 1, a member of the mammalian homolog of the yeast heterotrimeric CST telomeric capping complex. Consistent with the observation of shortened telomeres in an Arabidopsis CTC1 mutant and the phenotypic overlap of Coats plus with the telomeric maintenance disorders comprising dyskeratosis congenita, we observed shortened telomeres in three individuals with Coats plus and an increase in spontaneous gamma H2AX-positive cells in cell lines derived from two affected individuals. CTC1 is also a subunit of the alpha-accessory factor (AAF) complex, stimulating the activity of DNA polymerase-alpha primase, the only enzyme known to initiate DNA replication in eukaryotic cells. Thus, CTC1 may have a function in DNA metabolism that is necessary for but not specific to telomeric integrity.
  •  
3.
  • Anders, Bébhinn, et al. (author)
  • Wildfires and Monsoons: Cryptic Drivers for Highly Variable Provenance Signals within a Carboniferous Fluvial System
  • 2022
  • In: Geosciences. - : MDPI AG. - 2076-3263. ; 12:1, s. 20-20
  • Journal article (peer-reviewed)abstract
    • Sediment delivery and supply are explicitly controlled by variations in broad-scale processes such as climate, tectonics and eustasy. These in turn influence fluvial processes and hinterland evolution. A bespoke multi-proxy approach (integrating apatite and zircon U-Pb geochronology, trace elements in apatite, and Pb-in-K-feldspar provenance tools) coupled with outcrop investigation is used to constrain the temporal trends in sediment delivery to channel sandstones of the fluvio-estuarine mid-Viséan Mullaghmore Sandstone Formation, Ireland. Provenance data indicate unique detrital signatures for all sampled horizons, indicating the fluctuating nature of sediment supply to this medium-sized basin. Tectonism and/or abrupt relative sea-level fall likely caused fluvial rejuvenation, resulting in local basement sourcing of the initial fill. Older and more distal sources, such as the Nagssugtoqidian Belt of East Greenland, become more prominent in stratigraphically younger channel sandstones suggesting catchment expansion. Paleoproterozoic to Mesoproterozoic sources are most dominant, yet the detrital grain cargo varies in each channel sandstone. Proximal sources such as the Donegal Batholith and Dalradian Supergroup are variable and appear to switch on and off. These signal shifts are likely the result of channel migration and paleoclimatic fluctuation. A monsoonal climate and large-scale wildfire events (evidenced by fusain) likely contributed to modify plant cover, intensify erosion, and increase run-off and sediment delivery rates from specific areas of the hinterland.
  •  
4.
  • Lacas, Benjamin, et al. (author)
  • Role of radiotherapy fractionation in head and neck cancers (MARCH) : an updated meta-analysis
  • 2017
  • In: The Lancet Oncology. - 1470-2045 .- 1474-5488. ; 18:9, s. 1221-1237
  • Journal article (peer-reviewed)abstract
    • Background The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) showed that altered fractionation radiotherapy is associated with improved overall and progression-free survival compared with conventional radiotherapy, with hyperfractionated radiotherapy showing the greatest benefit. This update aims to confirm and explain the superiority of hyperfractionated radiotherapy over other altered fractionation radiotherapy regimens and to assess the benefit of altered fractionation within the context of concomitant chemotherapy with the inclusion of new trials. Methods For this updated meta-analysis, we searched bibliography databases, trials registries, and meeting proceedings for published or unpublished randomised trials done between Jan 1, 2009, and July 15, 2015, comparing primary or postoperative conventional fractionation radiotherapy versus altered fractionation radiotherapy (comparison 1) or conventional fractionation radiotherapy plus concomitant chemotherapy versus altered fractionation radiotherapy alone (comparison 2). Eligible trials had to start randomisation on or after Jan 1, 1970, and completed accrual before Dec 31, 2010; had to have been randomised in a way that precluded prior knowledge of treatment assignment; and had to include patients with non-metastatic squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx undergoing first-line curative treatment. Trials including a non-conventional radiotherapy control group, investigating hypofractionated radiotherapy, or including mostly nasopharyngeal carcinomas were excluded. Trials were grouped in three types of altered fractionation: hyperfractionated, moderately accelerated, and very accelerated. Individual patient data were collected and combined with a fixed-effects model based on the intention-to-treat principle. The primary endpoint was overall survival. Findings Comparison 1 (conventional fractionation radiotherapy vs altered fractionation radiotherapy) included 33 trials and 11 423 patients. Altered fractionation radiotherapy was associated with a significant benefit on overall survival (hazard ratio [HR] 0·94, 95% CI 0·90–0·98; p=0·0033), with an absolute difference at 5 years of 3·1% (95% CI 1·3–4·9) and at 10 years of 1·2% (−0·8 to 3·2). We found a significant interaction (p=0·051) between type of fractionation and treatment effect, the overall survival benefit being restricted to the hyperfractionated group (HR 0·83, 0·74–0·92), with absolute differences at 5 years of 8·1% (3·4 to 12·8) and at 10 years of 3·9% (−0·6 to 8·4). Comparison 2 (conventional fractionation radiotherapy plus concomitant chemotherapy versus altered fractionation radiotherapy alone) included five trials and 986 patients. Overall survival was significantly worse with altered fractionation radiotherapy compared with concomitant chemoradiotherapy (HR 1·22, 1·05–1·42; p=0·0098), with absolute differences at 5 years of −5·8% (−11·9 to 0·3) and at 10 years of −5·1% (−13·0 to 2·8). Interpretation This update confirms, with more patients and a longer follow-up than the first version of MARCH, that hyperfractionated radiotherapy is, along with concomitant chemoradiotherapy, a standard of care for the treatment of locally advanced head and neck squamous cell cancers. The comparison between hyperfractionated radiotherapy and concomitant chemoradiotherapy remains to be specifically tested. Funding Institut National du Cancer; and Ligue Nationale Contre le Cancer.
  •  
5.
  •  
6.
  • Owens, Kay, et al. (author)
  • Cultural horizons for mathematics
  • 2011
  • In: Mathematics Education Research Journal. - : Springer Science and Business Media LLC. - 1033-2170 .- 2211-050X. ; 23:2, s. 253-274
  • Journal article (peer-reviewed)abstract
    • As a result of a number of government reports, there have been numerous systemic changes in Indigenous education in Australia revolving around the importance of partnerships with the community. A forum with our local Dubbo community established the importance of working together and developed a model which placed the child in an ecological perspective that particularly noted the role of Elders and the place of the child in the family. However, there was also the issue of curriculum and mathematics education to be addressed. It was recognised that a colonised curriculum reduces the vision of what might be the potential for Indigenous mathematics education. This paper reports on the sharing that developed between our local community and some researchers and teachers from Sweden, Papua New Guinea and New Zealand. It has implications for recognising the impact of testing regimes, the teaching space, understanding the ways children learn, the curriculum, and teacher education. As a result of these discussions, a critical pedagogy that considers culture and place is presented as an ecocultural perspective on mathematics education. This perspective was seen as critical for the curriculum and learning experiences of Indigenous children.
  •  
7.
  • Aburawi, Elhadi, et al. (author)
  • Relation of aortic root dilatation and age in Marfan's syndrome
  • 2007
  • In: European Heart Journal. - : Oxford University Press (OUP). - 1522-9645 .- 0195-668X. ; 28:3, s. 376-379
  • Journal article (peer-reviewed)abstract
    • Aims The main aim of this study was to describe the age at which pathological aortic root dilation occurs in patients with Marfan's syndrome (MFS). Methods and results A total of 160 patients with MFS attending a regional cardiac centre were reviewed retrospectively. Dilation of the ascending aorta was diagnosed by comparing the maximum aortic sinus measurement with control data from the literature. We employed a Kaplan-Meier survival curve to estimate the age at which dilatation occurs. The mean age of the total group at presentation was 15.5 years (range 1.5-40 years). Skeletal abnormalities were present in 95%. Eye involvement was found in 18%. In the 115/160 patients with an abnormal aortic root, 78/115 (68%) developed aortic root dilatation before 19 years of age. From the Kaplan-Meier curve, it can be estimated that about 35% of the patients have aortic root dilatation already at the age of 5 years and 70% before the age of 20 years, and at least 80% by 40 years. There were 31 patients with normal aortic root when first seen but 24/31 (77%) developed aortic root dilatation before the age of 19 years and 7/31 (22.6%) after 19 years of age. Of those (seven patients) who developed new pathological aortic root dilatation after age 19 years, the age range was between 21 and 40 years with a mean of 27 years. Overall, 13 patients (8%) had surgery for aortic root replacement. Conclusion Aortic root dilatation develops early in MFS and was present in 35% by the age of 5 years and 68% by 19 years. Even though new aortic root dilation is relatively rare, it is not possible to safely discharge patients with MFS as about one-third of the patients in our series who developed new pathological aortic root dilation did so after the age of 19 years.
  •  
8.
  • Axfors, Cathrine, et al. (author)
  • Association between convalescent plasma treatment and mortality in COVID-19 : a collaborative systematic review and meta-analysis of randomized clinical trials
  • 2021
  • In: BMC Infectious Diseases. - : BioMed Central (BMC). - 1471-2334. ; 21:1
  • Research review (peer-reviewed)abstract
    • Background: Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of trials. The objective of this study was to assess the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19, using data from all available randomized clinical trials, including unpublished and ongoing trials (Open Science Framework, ). Methods: In this collaborative systematic review and meta-analysis, clinical trial registries (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform), the Cochrane COVID-19 register, the LOVE database, and PubMed were searched until April 8, 2021. Investigators of trials registered by March 1, 2021, without published results were contacted via email. Eligible were ongoing, discontinued and completed randomized clinical trials that compared convalescent plasma with placebo or no treatment in COVID-19 patients, regardless of setting or treatment schedule. Aggregated mortality data were extracted from publications or provided by investigators of unpublished trials and combined using the Hartung-Knapp-Sidik-Jonkman random effects model. We investigated the contribution of unpublished trials to the overall evidence. Results: A total of 16,477 patients were included in 33 trials (20 unpublished with 3190 patients, 13 published with 13,287 patients). 32 trials enrolled only hospitalized patients (including 3 with only intensive care unit patients). Risk of bias was low for 29/33 trials. Of 8495 patients who received convalescent plasma, 1997 died (23%), and of 7982 control patients, 1952 died (24%). The combined risk ratio for all-cause mortality was 0.97 (95% confidence interval: 0.92; 1.02) with between-study heterogeneity not beyond chance (I-2 = 0%). The RECOVERY trial had 69.8% and the unpublished evidence 25.3% of the weight in the meta-analysis. Conclusions: Convalescent plasma treatment of patients with COVID-19 did not reduce all-cause mortality. These results provide strong evidence that convalescent plasma treatment for patients with COVID-19 should not be used outside of randomized trials. Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care.
  •  
9.
  •  
10.
  • Croll, Donald A., et al. (author)
  • Vulnerabilities and fisheries impacts : the uncertain future of manta and devil rays
  • 2016
  • In: Aquatic conservation. - : Wiley. - 1052-7613 .- 1099-0755. ; 26:3, s. 562-575
  • Research review (peer-reviewed)abstract
    • 1. Manta and devil rays of the subfamily Mobulinae (mobulids) are rarely studied, large, pelagic elasmobranchs, with all eight of well-evaluated species listed on the IUCN Red List as threatened or near threatened. 2. Mobulids have life history characteristics (matrotrophic reproduction, extremely low fecundity, and delayed age of first reproduction) that make them exceptionally susceptible to overexploitation. 3. Targeted and bycatch mortality from fisheries is a globally important and increasing threat, and targeted fisheries are incentivized by the high value of the global trade in mobulid gill plates. 4. Fisheries bycatch of mobulids is substantial in tuna purse seine fisheries. 5. Thirteen fisheries in 12 countries specifically targeting mobulids, and 30 fisheries in 23 countries with mobulid bycatch were identified. 6. Aside from a few recently enacted national restrictions on capture, there is no comprehensive monitoring, assessment or control of mobulid fisheries or bycatch. Recent listing through the Convention on the International Trade in Endangered Species (CITES) may benefit mobulids of the genus Manta (manta rays), but none of the mobulids in the genus Mobula (devil rays) are protected. 7. The relative economic costs of catch mitigation are minimal, particularly compared with a broad range of other, more complicated, marine conservation issues. Copyright (C) 2015 John Wiley & Sons, Ltd.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 29
Type of publication
journal article (24)
research review (5)
Type of content
peer-reviewed (28)
other academic/artistic (1)
Author/Editor
O'Sullivan, John (6)
Nilsson, Sten (3)
Widmark, Anders (3)
Atkin, Owen K (3)
Tjoelker, Mark G (3)
Olsson, Håkan (2)
show more...
Sunnari, Vappu (2)
Hakansson, N. (2)
Zheng, W. (2)
Kaaks, R. (2)
Shu, XO (2)
Fossa, Sophie D. (2)
Huntingford, Chris (2)
Fernando, Daniel (2)
Melander, Olle (2)
Horellou, Cathy, 196 ... (2)
Cohen, P (2)
Burke, J (2)
Zackrisson, Björn (2)
Poulsen, Michael (2)
Hopper, JL (2)
Peto, J (2)
Chang-Claude, J (2)
John, EM (2)
Solberg, Arne (2)
Gapstur, SM (2)
Vasan, Ramachandran ... (2)
Poewe, Werner (2)
Lees, Andrew (2)
Cotter, Paul D. (2)
Ross, R. Paul (2)
Pignon, Jean-Pierre (2)
Hurry, Vaughan (2)
Gerszten, Robert E (2)
Johansson, Gunilla (2)
Rookus, MA (2)
Sartor, Oliver (2)
Menon, U (2)
Bottomley, David (2)
Jannok Nutti, Ylva (2)
Wang, Thomas J (2)
Bourhis, Jean (2)
Clish, Clary B (2)
Croll, Donald A. (2)
Poortvliet, Marloes (2)
Stevens, Guy (2)
O’Sullivan, Dominic (2)
Meir, Patrick (2)
Owens, Kay (2)
Overgaard, Jens (2)
show less...
University
Lund University (9)
Umeå University (8)
Uppsala University (5)
Karolinska Institutet (5)
Luleå University of Technology (2)
Örebro University (2)
show more...
Chalmers University of Technology (2)
Linnaeus University (2)
Swedish University of Agricultural Sciences (2)
Royal Institute of Technology (1)
Stockholm University (1)
Linköping University (1)
Swedish Museum of Natural History (1)
show less...
Language
English (29)
Research subject (UKÄ/SCB)
Medical and Health Sciences (16)
Natural sciences (10)
Social Sciences (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view